CC
SGYP

Callan Capital’s Synergy Pharmaceuticals, Inc Common Stock SGYP Stock Holding History

Callan Capital’s Portfolio SGYP Stock Details SGYP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-150,100
Closed -$1.25M – 75
2015
Q2 		$1.25M Sell
150,100
-111,122
-43% -$539K 0.26% 40
2015
Q1 		$1.21M Buy
261,222
+19,877
+8% +$64.6K 0.26% 39
2014
Q4 		$736K Buy
241,345
+123,145
+104% +$364K 0.17% 48
2014
Q3 		$329K Sell
118,200
-14,000
-11% -$50.8K 0.09% 55
2014
Q2 		$538K Buy
132,200
+122,200
+1,222% +$519K 0.14% 46
2014
Q1 		$53K Sell
10,000
-140
-1% -$785 0.02% 51
2013
Q4 		$56K Buy
+10,140
New +$43.7K 0.02% 47

Other funds holding SGYP

PC
Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return